Dr. Brook L. Brouha, MD, PhD

Dr. Brouha practices at Cosmetic Laser Dermatology in San Diego, California.

Dr. Brouha's NPI, 1114173937, was assigned on August 12, 2008. Dr. Brouha graduated from Perelman School of Medicine - Philadelphia in 2005. Dr. Brouha holds California license A97902.

Dr. Brouha's primary practice is Cosmetic Laser Dermatology, at 9339 Genesee Avenue, Suite 300, San Diego, CA 92121. The practice phone is (858) 657-1002.

Dr. Brouha's primary practice is Cosmetic Laser Dermatology in San Diego, California. The medical group on file is West Dermatology. Dmand AI also links Dr. Brouha to 2 more group practices and clinics and 1 medical group, each named with a free account. Dr. Brouha's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brouha practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatopathology is Dr. Brouha's primary specialty in the NPI Registry, under taxonomy code 207ND0900X. Dr. Brouha is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Brouha's licenses on file in 15 states: California, Oregon, Arizona, Texas, Utah, Idaho, Michigan, Pennsylvania, Rhode Island, Colorado, Delaware, Montana, Ohio, Washington and Wisconsin.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, facial skin infection, hives and itchy rashes among the conditions Dr. Brouha treats.

CMS data shows 15,258 Medicare services from Dr. Brouha across 19 procedure codes in 2024, for 967 Medicare patients. Medicare paid $268,517 for them. Every service was in an office.

CMS counts 967 Medicare patients who saw Dr. Brouha in 2024. The largest group is 65 to 74, with 488 patients. 74% of them have high cholesterol, and 54% have high blood pressure. 7% are also on Medicaid. Their average risk score is 0.90, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Brouha's median patient age at 60, with 54% women.

In 2024, Dr. Brouha wrote 1,498 Medicare Part D claims for 481 patients. 93% of them were for generic drugs. CMS names the drug for 1,303 of them, across 22 drugs with 11 or more claims each, at $329,247 in total drug cost. In 2023, CMS named 1,119 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Brouha for performance year 2024, reported as part of a group. Dr. Brouha accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,679 procedures of removal of skin lesions by Dr. Brouha, more than 97% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin cancer: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Brouha, published from 2002 to 2006. 2006 was the busiest year, with 2. The most frequent topics are Apoptosis, Caspases and Inhibitor of Apoptosis Proteins. Dr. Brouha's most frequent co-authors are Clay J. Cockerell, MD, Antoanella Calame, MD and Charles Chiang, MD.

CMS Open Payments shows 1,001 general payments to Dr. Brouha from 42 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. Abbvie Inc. paid the most, $2,681.

Dmand AI lists 2 awards for Dr. Brouha, most recently AAD Fellow in 2013.

Dr. Brouha graduated from Perelman School of Medicine - Philadelphia in 2005. Dr. Brouha is a member of AAD.

Dr. Brouha is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.